The price of Xolair (omalizumab) varies significantly depending on factors such as dosage, treatment duration, insurance coverage, and geographic location. While specific pricing information is not publicly disclosed by the manufacturer, Genentech, it is generally considered a high-cost medication due to its specialized nature and the research and development involved.
How much does Xolair cost without insurance?
Without insurance, the cost of Xolair can be substantial, potentially running into thousands of dollars per month. Patients often explore financial assistance programs offered by the manufacturer or third-party organizations to help offset these expenses.
What is the typical dosage and administration of Xolair?
Xolair is administered via subcutaneous injection. The dosage and frequency of injections are individualized based on a patient's baseline immunoglobulin E (IgE) levels and body weight. Typical doses range from 75 mg to 375 mg every two to four weeks [1].
Are there patient assistance programs for Xolair?
Genentech offers the Genentech Access to Care program, which provides support for eligible patients needing assistance with co-pays, co-insurance, or the full cost of their medication [2]. Other patient advocacy groups may also offer financial aid or resources for individuals managing chronic conditions treated by Xolair.
What conditions does Xolair treat?
Xolair is approved for the treatment of several allergic and inflammatory conditions. These include moderate to severe persistent allergic asthma in adults and adolescents 12 years of age and older whose asthma is not controlled with inhaled corticosteroids [1]. It is also used for chronic idiopathic urticaria (hives) in adults and adolescents 12 years and older who have persistent hives despite H1-antihistamine treatment, and for nasal polyps in adults [1].
How does Xolair work?
Xolair is a monoclonal antibody that works by binding to immunoglobulin E (IgE) antibodies. IgE is a key player in the allergic inflammatory response. By binding to IgE, Xolair prevents it from binding to mast cells and basophils, thereby reducing the release of inflammatory mediators that contribute to allergic symptoms [1].
When does Xolair's patent expire?
Drug patent expiry dates are crucial for understanding potential market competition from generics or biosimilars. Information on Xolair's patent status and expiration can be found through resources that track drug patents. According to DrugPatentWatch.com, patent information for Xolair can be accessed to determine when market exclusivity might end [3].
Can biosimilars of Xolair become available?
The development of biosimilars for biologic drugs like Xolair is a complex process governed by regulatory pathways. If patents expire and regulatory approvals are granted, biosimilar versions of Xolair could potentially enter the market, which might influence pricing.
What are the common side effects of Xolair?
Common side effects reported in clinical trials include injection site reactions (pain, swelling, redness, itching), pain, and headache [1]. Less common but more serious side effects, such as anaphylaxis, have also been reported and require immediate medical attention [1].
How is Xolair administered and what is the treatment duration?
Xolair is given as an injection by a healthcare professional. The duration of treatment is determined by the patient's physician, based on the condition being treated and the patient's response to the medication. Treatment is typically ongoing for chronic conditions.
---
Sources:
[1] https://www.gene.com/medicines/xolair
[2] https://www.gene.com/patients/patient-support/access-to-care
[3] https://www.drugpatentwatch.com/